Skip to main content
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. — Investor Relations & Filings

Ticker · MRKR ISIN · US57055L1070 US Manufacturing
Filings indexed 899 across all filing types
Latest filing 2006-11-21 Interim / Quarterly Rep…
Country US United States of America
Listing US MRKR

About Marker Therapeutics, Inc.

https://markertherapeutics.com/

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematologic malignancies and solid tumors. The company's core technology is its Multi-Antigen Recognizing (MAR) T cell platform, which utilizes natural, non-genetically modified T cells to recognize and kill heterogeneous tumors. This approach is designed to provide durable anti-tumor responses with a favorable safety profile. Its lead product candidate, MT-601, recognizes six tumor-specific antigens and is being evaluated in a Phase 1 study for patients with lymphoma who have relapsed or are ineligible for anti-CD19 CAR-T cell therapy. The technology was originally developed at Baylor College of Medicine.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is described as a 'Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2006.' It contains detailed unaudited consolidated interim financial statements including balance sheets, statements of operations, stockholders' deficit, cash flows, and notes to the financial statements. The length of the document is 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of actual financial data and analysis confirms it is a quarterly financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2006-11-21 English
Regulatory Filings 2006
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC. It specifically states that the company, Genemax Corp., is unable to file its interim report on Form 10-QSB for the period ended September 30, 2006, within the prescribed time due to delays in obtaining necessary business information and auditor review. The form requests an extension for filing the quarterly report. The document does not contain the actual financial statements or substantive financial data but is a notification about the delay in filing the interim/quarterly report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a certification/notification related to a report but does not contain the report itself.
2006-11-14 English
Interim / Quarterly Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Form 10-QSB Quarterly Report' for the quarterly period ended June 30, 2006, filed with the U.S. Securities and Exchange Commission. It contains detailed unaudited consolidated interim financial statements including balance sheets, statements of operations, stockholders' deficit, cash flows, and notes to the financial statements. The presence of comprehensive financial data and analysis for a quarterly period, along with the SEC form designation 10-QSB, clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification but the actual report itself.
2006-08-21 English
Regulatory Filings 2006
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC. It specifically states it is a notification related to a late filing of a Form 10-QSB for the period ended June 30, 2006. The document explains the reasons for the delay and requests an extension for filing the interim report. It does not contain the actual financial statements or substantive financial data but is rather a regulatory notification about the delay in filing. According to the rules, such officer certifications or notifications about report filings should be classified as Regulatory Filings (RNS), not as the report itself (IR). The document length is 4251 characters, which is relatively short and consistent with a notification form rather than a full report.
2006-08-14 English
Interim / Quarterly Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Form 10-QSB' and is explicitly described as a 'Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2006.' It contains detailed unaudited consolidated financial statements, including balance sheets, statements of operations, cash flows, and notes. It also includes management's discussion and analysis, legal proceedings, and other information typical of a quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual quarterly report, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2006-05-19 English
Regulatory Filings 2006
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, Genemax Corp., is notifying the SEC of a delay in filing its quarterly report on Form 10-QSB for the period ended March 31, 2006. The document explains the reasons for the delay and requests an extension. It does not contain the actual financial statements or substantive financial data of the 10-QSB report itself, but rather is an announcement related to the filing status of that report. The document length is 4212 characters, which is relatively short and consistent with a notification form rather than a full report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the filing status and not the report itself.
2006-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.